Advertisement

Aquablation Outcomes in Men With LUTS Due to BPH Following Single Versus Multi-pass Treatments

      Abstract

      OBJECTIVE

      To determine whether existing data support the use of multiple passes in Aquablation for LUTS due to BPH.

      METHODS

      Data were obtained from 2sources. The WATER trial (NCT02505919) is a prospective, multicenter, double-blind, randomized controlled trial of Aquablation vs TURP in prostate volumes of 30 - 80 ml. The WATER II trial (NCT03123250) is a prospective single-arm multicenter trial of Aquablation in prostate volumes of 80-150ml. The number of passes was determined by the procedural data collected and the video recordings of all study cases.

      RESULTS

      In total, 127 Aquablation subjects underwent a single pass, 90 underwent multiple passes (80 had 2passes and 10 underwent 3passes), and 65 underwent TURP (in WATER only). Men undergoing 2or more passes with Aquablation had larger prostates but few differences in other baseline parameters, including prostate size range. Compared to a single pass, the use of 2or more passes during Aquablation resulted in lower IPSS scores (by ∼4 points, P = .0002) and lower IPSS QoL scores (by ∼0.7 points, P = .0096) at the later timepoints of 24 and 36 months. Similarly, 36-month Qmax values were higher (by ∼5 ml/sec, P = .0220) in those with 2or more passes than in those with 1pass. There was no statistically significant difference in ejaculatory dysfunction between groups.

      CONCLUSION

      Independent of prostate volume, a multiple treatment pass protocol led to improved voiding outcomes and IPSS improvement.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Franco JV
        • Jung JH
        • Imamura M
        • et al.
        Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
        Cochrane Database Syst Rev. 2021; 7CD013656
        • Gilling P
        • Barber N
        • Bidair M
        • et al.
        Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
        Can J Urol. 2020; 27: 10072-10079
      1. Zorn KC, Bidair M, Trainer A, et al. Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass Available at: https://onlinelibrary.wiley.com/doi/abs/10.1002/bco2.121, Accessed November 15, 2021.

        • Bach T
        • Gilling P
        • El Hajj A
        • Anderson P
        • Barber N
        First multi-center all-comers study for the aquablation procedure.
        J Clin Med. 2020; 9 (PMID: 32102329; PMCID: PMC7073705): 603https://doi.org/10.3390/jcm9020603
        • Misrai V
        • Rijo E
        • Zorn KC
        • et al.
        Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first french aquablation clinical registry.
        Eur Urol. 2019; 76: 667-675
        • Elterman D
        • Gilling P
        • Roehrborn C
        • et al.
        Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies.
        BMJ Surg Interv Health Technologies. 2021; 3e000090
        • Gilling P
        • Barber N
        • Bidair M
        • et al.
        WATER: a double-blind, randomized, controlled trial of aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia.
        J Urol. 2018; 199: 1252-1261
        • Gilling PJ
        • Barber N
        • Bidair M
        • et al.
        Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
        Can J Urol. 2022; 29: 10960-10968
        • Soyama H
        Cavitating jet: a review.
        Appl Sci. 2020; 10: 7280
        • Elterman D
        • Bach T
        • Rijo E
        • et al.
        Transfusion rates after 800 aquablation procedures using various hemostasis methods.
        BJU Int. 2020; 125 (Epub 2020 Jan 24. PMID: 31901210; PMCID: PMC7187336): 568-572https://doi.org/10.1111/bju.14990
        • Elterman DS
        • Foller S
        • Ubrig B
        • et al.
        Focal bladder neck cautery associated with low rate of post-Aquablation bleeding.
        Can J Urol. 2021; 28: 10610-10613